
N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation : Insights From the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)
Keywords: atrial fibrillation; natriuretic peptides; NT-proBNP; risk assessmentAF, atrial fibrillation; CI, confidence interval; HR, hazard ratio; IDI, integrated discrimination improvement; ISTH, International Society on Thrombosis and Haemostasis; NRI, net reclas